Andrea Corcoran

Insider Reports History

Entity
Individual
Location
125 Summer Street, 16 Th Floor, Boston, MA
Signature
/s/ Andrea Corcoran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrea Corcoran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Common Stock 670K $2.58M $3.84 Feb 1, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Restricted Stock Units 88.7K $341K $3.85 Jan 31, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Financial Officer, Executive Vice President, Legal and Secretary Stock Option (Right to Buy) 200K Jan 31, 2024 Direct

Insider Reports Filed by Andrea Corcoran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2024 4 -$60.9K 4 Feb 2, 2024 Chief Financial Officer, Executive Vice President, Legal and Secretary
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Financial Officer, Executive Vice President, Legal and Secretary
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Financial Officer, Executive Vice President, Legal and Secretary